The pore structure of Clostridium perfringens epsilon toxin.
Animals
Bacterial Toxins
/ chemistry
Biotechnology
/ methods
Cell Line
Clostridium Infections
/ microbiology
Clostridium perfringens
/ genetics
Cryoelectron Microscopy
Dogs
Enterotoxemia
/ microbiology
Models, Molecular
Mutagenesis, Site-Directed
Nanotechnology
/ methods
Protein Conformation, beta-Strand
/ genetics
Protein Multimerization
/ genetics
Recombinant Proteins
/ chemistry
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
14 06 2019
14 06 2019
Historique:
received:
20
12
2018
accepted:
20
05
2019
entrez:
16
6
2019
pubmed:
16
6
2019
medline:
10
7
2019
Statut:
epublish
Résumé
Epsilon toxin (Etx), a potent pore forming toxin (PFT) produced by Clostridium perfringens, is responsible for the pathogenesis of enterotoxaemia of ruminants and has been suggested to play a role in multiple sclerosis in humans. Etx is a member of the aerolysin family of β-PFTs (aβ-PFTs). While the Etx soluble monomer structure was solved in 2004, Etx pore structure has remained elusive due to the difficulty of isolating the pore complex. Here we show the cryo-electron microscopy structure of Etx pore assembled on the membrane of susceptible cells. The pore structure explains important mutant phenotypes and suggests that the double β-barrel, a common feature of the aβ-PFTs, may be an important structural element in driving efficient pore formation. These insights provide the framework for the development of novel therapeutics to prevent human and animal infections, and are relevant for nano-biotechnology applications.
Identifiants
pubmed: 31201325
doi: 10.1038/s41467-019-10645-8
pii: 10.1038/s41467-019-10645-8
pmc: PMC6572795
doi:
Substances chimiques
Bacterial Toxins
0
Clostridium perfringens epsilon-toxin
0
Recombinant Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2641Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_17136
Pays : United Kingdom
Organisme : RCUK | Medical Research Council (MRC)
ID : MC-A021-53019
Pays : International
Organisme : Wellcome Trust (Wellcome)
ID : WT089618MA
Pays : International
Références
J Mol Biol. 2009 Feb 13;386(1):121-33
pubmed: 19094993
Biochim Biophys Acta. 1975 Nov 18;412(1):62-9
pubmed: 172146
Mol Biosyst. 2012 Aug;8(8):2097-105
pubmed: 22688384
Infect Immun. 2003 Feb;71(2):739-46
pubmed: 12540553
Nat Commun. 2016 Apr 06;7:11293
pubmed: 27048994
PLoS One. 2013 Oct 16;8(10):e76359
pubmed: 24146858
Elife. 2016 Mar 07;5:
pubmed: 26949259
Infect Immun. 1995 Jan;63(1):340-4
pubmed: 7806374
Nat Methods. 2017 Apr;14(4):331-332
pubmed: 28250466
J Mol Biol. 2011 Oct 14;413(1):138-49
pubmed: 21839091
Biophys J. 2010 Aug 4;99(3):782-9
pubmed: 20682255
Nat Struct Mol Biol. 2004 Aug;11(8):797-8
pubmed: 15258571
Philos Trans R Soc Lond B Biol Sci. 2017 Aug 5;372(1726):
pubmed: 28630149
PLoS One. 2011;6(6):e20349
pubmed: 21687664
Microbiol Rev. 1982 Mar;46(1):86-94
pubmed: 6806598
J Biol Chem. 2001 May 11;276(19):15736-40
pubmed: 11278669
Toxicon. 2013 Dec 1;75:122-35
pubmed: 23632158
Protein Sci. 2013 May;22(5):650-9
pubmed: 23504825
J Biol Chem. 2001 Apr 27;276(17):13778-83
pubmed: 11278924
J Struct Biol. 2016 Jan;193(1):1-12
pubmed: 26592709
Toxicon. 1991;29(2):211-7
pubmed: 2048139
Nat Struct Biol. 2002 Oct;9(10):729-33
pubmed: 12219082
Biochim Biophys Acta. 2009 Dec;1788(12):2584-93
pubmed: 19835840
J Nat Toxins. 1998 Oct;7(3):291-302
pubmed: 9783265
Biochim Biophys Acta. 2008 Mar;1780(3):612-8
pubmed: 17980968
Hum Exp Toxicol. 1996 Nov;15(11):904-8
pubmed: 8938486
Biochemistry. 2006 Jan 10;45(1):296-302
pubmed: 16388606
Mult Scler. 2019 Apr;25(5):653-660
pubmed: 29681209
Nat Commun. 2016 May 12;7:11598
pubmed: 27176125
Nat Chem Biol. 2013 Oct;9(10):623-9
pubmed: 23912165
Infect Immun. 1977 Nov;18(2):549-51
pubmed: 200566
J Bacteriol. 1997 Oct;179(20):6480-7
pubmed: 9335299
Clin Infect Dis. 1998 Aug;27(2):332-44
pubmed: 9709884
PLoS One. 2011;6(7):e22053
pubmed: 21814565
Acta Crystallogr D Struct Biol. 2018 Jun 1;74(Pt 6):531-544
pubmed: 29872004
J Biol Chem. 2015 May 22;290(21):13191-201
pubmed: 25847242
Toxicol In Vitro. 1995 Jun;9(3):213-8
pubmed: 20650081
FEBS J. 2011 Dec;278(23):4589-601
pubmed: 21518257
FEBS Lett. 1996 Apr 22;384(3):269-72
pubmed: 8617369
J Biol Chem. 2005 Jun 17;280(24):22847-55
pubmed: 15824108
Elife. 2018 Nov 09;7:
pubmed: 30412051
Vaccine. 2014 May 13;32(23):2682-7
pubmed: 24709588
Adv Drug Deliv Rev. 2005 Jun 17;57(9):1424-39
pubmed: 15935880
Elife. 2019 Mar 12;8:
pubmed: 30860024
Sci Rep. 2017 Oct 24;7(1):13932
pubmed: 29066778
Biochemistry. 2012 Sep 25;51(38):7588-95
pubmed: 22938730
PLoS Pathog. 2015 May 20;11(5):e1004896
pubmed: 25993478
J Microbiol. 2015 Feb;53(2):141-6
pubmed: 25626370
EMBO J. 2006 Feb 8;25(3):457-66
pubmed: 16424900
J Biochem. 2011 Jan;149(1):103-15
pubmed: 20971989
Cell Microbiol. 2003 Mar;5(3):155-64
pubmed: 12614459
Microbiology (Reading). 1998 Feb;144 ( Pt 2):333-41
pubmed: 9493371
Nat Commun. 2016 Jul 13;7:12062
pubmed: 27405240
Microbiol Immunol. 1997;41(7):527-35
pubmed: 9272698